1
/
of
1
ELK Biotechnology
SKU:ELK7843
Human Anti-C1q(Anti-Complement 1q Antibody) ELISA Kit
Human Anti-C1q(Anti-Complement 1q Antibody) ELISA Kit
Regular price
$458.00 USD
Regular price
Sale price
$458.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Human Anti-C1q(Anti-Complement 1q Antibody) ELISA Kit
Overview
| Product name: | Human Anti-C1q(Anti-Complement 1q Antibody) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | C1-q Ab |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 0.58 ng/mL |
| Standard: | 100 ng/mL |
| Range: | 1.57-100 ng/mL |
| Sample Type: | Serum, plasma and other biological fluids |
| Assay Length: | 2h, 30min |
| Research Area: | Infection immunity;Immune molecule;Autoimmunity; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human Anti-C1q protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Anti-C1q. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Anti-C1q in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 100.00 | 0.183 | — |
| 50.00 | 0.310 | — |
| 25.00 | 0.451 | — |
| 12.50 | 0.846 | — |
| 6.25 | 1.389 | — |
| 3.13 | 1.439 | — |
| 1.57 | 1.761 | — |
| 0.00 | 2.316 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant Anti-C1q and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-C1q in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 86-99% | 92% |
| EDTA plasma(n=5) | 82-97% | 89% |
| Heparin plasma(n=5) | 80-95% | 87% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-C1q and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 87-96% | 85-97% | 85-94% | 87-96% |
| EDTA plasma(n=5) | 93-104% | 83-96% | 95-103% | 88-95% |
| Heparin plasma(n=5) | 89-102% | 92-101% | 88-102% | 87-102% |
Share
